World Congress on Preventive oncology
Date: July 27-28, 2017
Venue: Chicago, USA
Preventive Oncology 2017 will be organized around the theme “Exchange & Translation of scientific Information on preventive Oncology”.
Preventive Oncology is comprised of many interactive scientific sessions on different types of cancers as well as various diagnostic and therapeutic advancements in this field. It is an initiative to unite the diverse research and business communities working in this field under a one roof to explore every single aspect of cancer Diseases. PreventiveOncology2017 welcomes the immunologists, pathologists, oncologists, research scholars, academicians, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it in preventive oncology conferences.
According to market study, market value of preventive oncology at present is $23.74 billion. A major part of research is going on at the top Universities across the globe, on Preventive Oncology conference and the grants allotted for this research field is around $16.94 billion. Many companies are associated with the blood testing equipment along with various diagnostic instruments, cancer drugs and other therapeutics, the revenue generated is around $29.1 billion on average by this companies. Besides this various societies and research labs are also associated in this research field.
Preventive Oncology conferences are organized by Conference Series LLC which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. Preventive Oncology 2016 will provide an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster and Live Streaming, B2B and Scientific Meetings.
Preventive Oncology 2017 emphasizes on the topics
which are not limited to:
Why to attend?
Preventive Oncology 2017 will provide a stimulating scientific environment and a platform for the participants to exchange ideas, establish research collaboration and networking by attending the Preventive Oncology conferences. New topics for 2016 include personalised medicines & combination therapies. Special focus on commercialisation of cancer vaccines – to increase your speed to market It will be amazing opportunity for the attendees to explore the beautiful city with gaining knowledge, sure to raise insights, conflate present with future and cogitate on ideas and reality in Preventive Oncology meetings. To fight against these hard to cure blood diseases, Preventive Oncology 2016 has taken this initiative to explore every aspects of Preventive Oncology research.
Target Audience
· Head/Director/CEO
· Director of Translational Research
· Medical Scientist
· Chief Medical Officer
· Principal Scientist
· R&D Project Leader
· Chief Scientific Officer
· Formulation Scientist
· Immunologists
· Pathologists
· Oncologists
· Research Scholars
· Industrial professionals from biomedical companies and healthcare sectors.
· Student delegates from Academia and Research along with the industrial professionals
No comments:
Post a Comment